Evidence map›Paper›PMID 30535731›Full record

ArticleAIDS and behavior2019

Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV.

Lauren M Hill, Carol E Golin, Nisha C Gottfredson, Brian W Pence, Bethany DiPrete, Jessica Carda-Auten, Jennifer S Groves, Sonia Napravnik, David Wohl, Kevin Knight and 1 more

Open access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lauren M HillDepartment of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. hilllm@email.unc.edu.ORCID http://orcid.org/0000-0001-9444-4435
Carol E GolinDepartment of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nisha C GottfredsonDepartment of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Brian W PenceDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Bethany DiPreteDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jessica Carda-AutenDepartment of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jennifer S GrovesCecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Sonia NapravnikDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
David WohlDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kevin KnightDepartment of Psychology, Texas Christian University, Fort Worth, TX, USA.
Patrick M FlynnDepartment of Psychology, Texas Christian University, Fort Worth, TX, USA.
University of North Carolina at Chapel Hill · USTexas Christian University · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
University of California, San Diego Clinical Trial UnitUM1AI069536 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEPHEN A SPECTOR · 2012 to 2026
$34.0M
Justice Community Opioid Innovation Network (JCOIN): TCU Clinical Research CenterUG1DA050074 · NIDA · TEXAS CHRISTIAN UNIVERSITY · PI KNIGHT, DANICA K, KNIGHT, KEVIN · 2019 to 2023
$10.1M
UNC-CH TRAINING PROGRAM IN HEALTH SERVICES RESEARCHT32HS000032 · AHRQ · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOLMES, GEORGE M · 1989 to 2024
$8.2M
RCT of an augmented test, treat, link, & retain model for NC and Texas prisonersR01DA030793 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLYNN, PATRICK M, GOLIN, CAROL E · 2010 to 2015
$6.9M
Mentoring New Investigators in Criminal Justice HIV Prevention and TreatmentK24DA037101 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WOHL, DAVID A · 2014 to 2018
$911k
Mentoring Junior Investigators: Comprehensive HIV PreventionK24HD069204 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GOLIN, CAROL E · 2013 to 2017
$789k
The Impact of Affect Regulatory Mechanisms and Binge Eating on Drug RecoveryK01DA035153 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GOTTFREDSON O'SHEA, NISHA · 2014 to 2018
$777k
Agency for Healthcare Research and Quality T32HS000032AHRQ HHS T32 HS000032Eunice Kennedy Shriver National Institute of Child Health and Human Development K24HD069204National Institute of Allergy and Infectious Diseases P30AI50410NIAID NIH HHS P30 AI050410NIAID NIH HHS UM1 AI069536NICHD NIH HHS K24 HD069204NIDA NIH HHS K01 DA035153NIDA NIH HHS K01DA035153NIDA NIH HHS K24 DA037101NIDA NIH HHS K24DA037101NIDA NIH HHS R01 DA030793NIDA NIH HHS R01DA030793NIMHD NIH HHS L60 MD013105
6 · The paper itself

Abstract

Depression is a known risk factor for antiretroviral therapy (ART) non-adherence, but little is known about the mechanisms explaining this relationship. Identifying these mechanisms among people living with HIV (PLHIV) after release from prison is particularly important, as individuals during this critical period are at high risk for both depression and poor ART adherence. 347 PLHIV recently released from prison in North Carolina and Texas were included in analyses to assess mediation of the relationship between depressive symptoms at 2 weeks post-release and ART adherence (assessed by unannounced telephone pill counts) at weeks 9-21 post-release by the hypothesized explanatory mechanisms of alcohol use, drug use, adherence self-efficacy, and adherence motivation (measured at weeks 6 and 14 post-release). Indirect effects were estimated using structural equation models with maximum likelihood estimation and bootstrapped confidence intervals. On average, participants achieved 79% ART adherence. The indirect effect of depression on adherence through drug use was statistically significant; greater symptoms of depression were associated with greater drug use, which was in turn associated with lower adherence. Lower adherence self-efficacy was associated with depressive symptoms, but not with adherence. Depression screening and targeted mental health and substance use services for depressed individuals at risk of substance use constitute important steps to promote adherence to ART after prison release.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveDepressionDrug MonitoringFemaleHIV InfectionsHumansMaleMedication AdherenceMental HealthMiddle AgedMotivationNorth CarolinaPrisonersRisk FactorsAnti-HIV AgentsAdherenceAntiretroviral therapyDepressionDrug useIncarcerationMediation

Identifiers

PMID30535731
PMCPMC6555693
OpenAlexW2905066666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.